Holen Sie sich die Stockscreener-App
2.37
2.07%
-0.05
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Costs And Expenses |
19.68%
1.555
|
1.936 | 1.60 | 1.577 | 1.837 |
| Depreciation and Amortization |
-
|
- | 0.003 | 0.002 | 0.012 |
| Operating Income/Loss |
19.68%
-1.555
|
-1.936 | -1.60 | -1.577 | -1.837 |
Net Income/Loss
|
30.97%
-1.326
|
-1.921 | -1.912 | -1.532 | -5.245 |
| Basic Average Shares |
0.00%
6.4062
|
6.4062 | - | 5.4358 | 5.087 |
| Diluted Average Shares |
0.00%
6.4062
|
6.4062 | - | 5.4358 | 5.087 |
| Basic Earnings Per Share |
30.00%
-0.21
|
-0.30 | - | -0.40 | -1.03 |
| Diluted Earnings Per Share |
30.00%
-0.21
|
-0.30 | - | -0.40 | -1.03 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):